联合健康将Vertex非阿片类止痛药纳入承保范围，但费用较高 - 彭博社
Investing.com -- 据彭博社报道，联合健康集团（UnitedHealth Group Inc.）已将Vertex制药公司（Vertex Pharmaceuticals Inc.）新获批的非阿片类止痛药Journavx纳入承保范围。然而，与联合健康批准药物清单上的其他止痛药相比，该药物被划分到了更高成本的等级。
Vertex Pharma drops as UnitedHealth offers Tier 3 coverage for new pain medicine
Vertex Pharma (VRTX) stock slips as UnitedHealth (UNH) offers its pain drug Journavx Tier 3 coverage, setting a rivalry with ...
Vertex non-opioid pain drug picked up by UnitedHealth
Vertex Pharmaceuticals’ (VRTX) non-opioid pain drug Journavx was picked up by UnitedHealth’s (UNH) Optum on “Tier 3.” The insurer said, ...
Vertex Pharmaceuticals Inc. stock rises Wednesday, still underperforms market
Shares of Vertex Pharmaceuticals Inc. VRTX advanced 1.11% to $491.64 Wednesday, on what proved to be an all-around favorable ...
Zacks Research Issues Pessimistic Outlook for VRTX Earnings
Equities researchers at Zacks Research decreased their Q3 2026 earnings per share (EPS) estimates for shares of Vertex ...
Barchart on MSN1 天
Vertex Pharmaceuticals Stock: Is VRTX Outperforming the Healthcare Sector?
With a market cap of $124.9 billion, Vertex Pharmaceuticals Incorporated (VRTX) is a global biotechnology company. The Boston ...
Vertex Pharmaceuticals: Company Passes My Health Check With Flying Colors, Upholding Buy Rating
Vertex Pharmaceuticals demonstrates resilience with robust CF franchise, new approvals, and diversification efforts. Read why ...
Vertex制药公司执行副总裁出售价值84.9万美元股票
根据证券交易委员会的Form 4文件显示，生物技术巨头Vertex Pharmaceuticals Inc.（NASDAQ:VRTX）执行副总裁兼首席技术运营官Edward Morrow Atkinson III近期出售了一批公司股票。该公司目前市值为1,231亿美元。据 InvestingPro ...
Vertex Pharmaceuticals Incorporated (VRTX): Among Renaissance Technologies Portfolio’s ...
We recently published a list of Renaissance Technologies Portfolio: Top 10 Stock Picks. In this article, we are going to take ...
Bernstein Sticks to Its Hold Rating for Vertex Pharmaceuticals (VRTX)
Bernstein analyst William Pickering maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report) yesterday and set a price ...
Investing.com India2 小时
UnitedHealth includes Vertex’s non-opioid painkiller in coverage, but at a higher cost ...
Investing.com -- Vertex Pharmaceuticals Inc (NASDAQ: VRTX ).’s newly approved non-opioid pain medication, Journavx, has been included in UnitedHealth Group Inc (NYSE: UNH ).’s coverage, according to ...
证券之星13 天
加拿大皇家银行：维持Vertex Pharmaceuticals(VRTX.US)评级
加拿大皇家银行：维持Vertex Pharmaceuticals(VRTX.US)评级，由与大盘持平调整至与大盘持平评级, 目标价由407.00美元调整至408.00美元。 福泰制药（VRTX.US ...